CD274 and cancer: Finally, the PD-L1 cut-off was also able to distinguish between patients with worse/better OS at univariate analysis (HR: 2.83, 95%CI 1.22–6.57, p = 0.016) and when adjusting for cancer site (p = 0.024) (Fig. 4, Supplementary Table 1).